People might also have muscle weakness, restless legs, headaches, coil a hand involuntarily, nerve inflammation, heightened reflexes, involuntary muscle twitching, and muscle cramps
These peptides are sold for lab use only and are not approved by the FDA for human use
Patients with neurological symptoms require more intensive treatment with alternate-day injections until improvement plateaus, and may need more frequent maintenance dosing
this area attracts attention from researchers studying tissue support, recovery speed, performance output, and the broader repair response
NICE does not currently have guidance on either AOD 9604 or retatrutide, reflecting their unlicensed and investigational status within the UK healthcare system